Skip to content

Effect of arnebia euchroma on prevention of phlebitis of angiocath

Effect of arnebia euchroma on prevention of phlebitis due to peripheral venous catheter.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017012432147N1
Enrollment
120
Registered
2017-06-09
Start date
2016-11-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Phlebitis. Phlebitis and thrombophlebitis of other sites

Interventions

Intervention 1: Intervention group: The method of intervention will be: after insertion of IV catheter ( with sterile way, in upper limb site, without signs of phlebitis), arnebia euchroma poultice w
Prevention
Intervention group: The method of intervention will be: after insertion of IV catheter ( with sterile way, in upper limb site, without signs of phlebitis), arnebia euchroma poultice will be apply to
Control group: The method of intervention will be: after insertion of IV catheter ( with sterile way, in upper limb site, without signs of phlebitis), placebo poultice will be apply to the skin, in th

Sponsors

Vice chancellor for research of Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 90 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria will be: hospitalized in CCU and heart wards; age between 35-90 years; awake and conscious; ability to understand and explain the pain; patient cooperation; without diabetes disease; without skin disorders and kinds of eczema; without sensitivity to IV tape; with out fever; don’t using chemotherapy; nitroglycerin and heparin. Exclusion criteria are: worsen the condition of patient; transfer the patient to ICU; discharge of patient and unwillingness to be in the study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Phlebitis. Timepoint: Before intervention, Every 12 hours over 72 hours, Immediately after intrvention. Method of measurement: VIP(visual infusion phlebitis score).

Secondary

MeasureTime frame
-. Timepoint: -. Method of measurement: -.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactBahareh Ghafourzadeh Toomatary

Tehran University of Medical Science , School of Nursing and Midwifery

b-ghafourzadeh@razi.tums.ac.ir+98 21 6692 7171

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026